Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab

about

Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab

Item

http://www.wikidata.org/entity/Q40985513

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Two Patients with Familial Hyp ...... fter Treatment with Evolocumab

@en

type

Item

label

Two Patients with Familial Hyp ...... fter Treatment with Evolocumab

@en

prefLabel

Two Patients with Familial Hyp ...... fter Treatment with Evolocumab

@en

P1476

Two Patients with Familial Hyp ...... fter Treatment with Evolocumab

@en

P2093

Akihito Tanaka

http://www.w3.org/2001/XMLSchema#string

Asami Takeda

http://www.w3.org/2001/XMLSchema#string

Daijo Inaguma

http://www.w3.org/2001/XMLSchema#string

Eri Ito

http://www.w3.org/2001/XMLSchema#string

Hibiki Shinjo

http://www.w3.org/2001/XMLSchema#string

Hiroya Shimogushi

http://www.w3.org/2001/XMLSchema#string

Kiyomi Koike

http://www.w3.org/2001/XMLSchema#string

Naoki Kamegai

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Otsuka

http://www.w3.org/2001/XMLSchema#string

Yu Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

Molecular biology of PCSK9: its role in LDL metabolism

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Single Low-Density Lipoprotein Apheresis Does Not Improve Vascular Endothelial Function in Chronically Treated Hypercholesterolemic Patients

PCSK9: From discovery to therapeutic applications.

Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 In

Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).

P304

1531-1535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2169/INTERNALMEDICINE.56.7958

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28626179

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

5505909

http://www.w3.org/2001/XMLSchema#string